CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms

REFERENCES

• Agata, Y., A. Kawasaki, H. Nishimura, Y. Ishida, T. Tsubata, H. Yagita, and T. Honjo. 1996. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8:765–772.
   PubMed Web of Science ®Google Scholar
• Appleman, L. J., A. A. Van Puijenbroek, K. M. Shu, L. M. Nadler, and V. A. Boussiotis. 2002. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. J. Immunol. 168:2729–2736.
   PubMed Web of Science ®Google Scholar
• Baroja, M. L., L. Vijayakrishnan, E. Bettelli, P. J. Darlington, T. A. Chau, V. Ling, M. Collins, B. M. Carreno, J. Madrenas, and V. K. Kuchroo. 2002. Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A. J. Immunol. 168:5070–5078.
   PubMed Web of Science ®Google Scholar
• Barthel, A., S. T. Okino, J. F. Liao, K. Nakatani, J. P. Li, J. P. Whitlock, and R. A. Roth. 1999. Regulation of GLUT1 gene transcription by the serine threonine kinase Akt1. J. Biol. Chem. 274:20281–20286.
   PubMed Web of Science ®Google Scholar
• Bennett, F., D. Luxenberg, V. Ling, I. M. Wang, K. Marquette, D. Lowe, N. Khan, G. Veldman, K. A. Jacobs, V. E. Valge-Archer, M. Collins, and B. M. Carreno. 2003. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J. Immunol. 170:711–718.
   PubMed Web of Science ®Google Scholar
• Bialojan, C., and A. Takai. 1988. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem. J. 256:283–290.
   PubMed Web of Science ®Google Scholar
• Blair, P. J., J. L. Riley, B. L. Levine, K. P. Lee, N. Craighead, T. Francomano, S. J. Perfetto, G. S. Gray, B. M. Carreno, and C. H. June. 1998. CTLA-4 ligation delivers a unique signal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X(L) induction. J. Immunol. 160:12–15.
   PubMed Web of Science ®Google Scholar
• Boise, L. H., A. J. Minn, P. J. Noel, C. H. June, M. A. Accavitti, T. Lindsten, and C. B. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3:87–98.
   PubMed Web of Science ®Google Scholar
• Carreno, B. M., F. Bennett, T. A. Chau, V. Ling, D. Luxenberg, J. Jussif, M. L. Baroja, and J. Madrenas. 2000. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J. Immunol. 165:1352–1356.
   PubMed Web of Science ®Google Scholar
• Carreno, B. M., and M. Collins. 2002. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20:29–53.
   PubMed Web of Science ®Google Scholar
• Cazzolli, R., L. Carpenter, T. J. Biden, and C. Schmitz-Peiffer. 2001. A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate. Diabetes 50:2210–2218.
   PubMedGoogle Scholar
• Chambers, C. A., M. S. Kuhns, and J. P. Allison. 1999. Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses. Proc. Natl. Acad. Sci. USA 96:8603–8608.
   PubMed Web of Science ®Google Scholar
• Chambers, C. A., T. J. Sullivan, T. Truong, and J. P. Allison. 1998. Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells. Eur. J. Immunol. 28:3137–3143.
   PubMed Web of Science ®Google Scholar
• Chan, T. O., S. E. Rittenhouse, and P. N. Tsichlis. 1999. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 68:965–1014.
   PubMed Web of Science ®Google Scholar
• Chan, T. O., and P. N. Tsichlis. 2001. PDK2: a complex tail in one Akt. Sci. STKE 2001:E1.
   Google Scholar
• Chemnitz, J. M., R. V. Parry, K. E. Nichols, C. H. June, and J. L. Riley. 2004. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J. Immunol. 173:945–954.
   PubMed Web of Science ®Google Scholar
• Chuang, E., T. S. Fisher, R. W. Morgan, M. D. Robbins, J. M. Duerr, M. G. Vander Heiden, J. P. Gardner, J. E. Hambor, M. J. Neveu, and C. B. Thompson. 2000. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity 13:313–322.
   PubMed Web of Science ®Google Scholar
• Cinek, T., A. Sadra, and J. B. Imboden. 2000. Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4. J. Immunol. 164:5–8.
   PubMed Web of Science ®Google Scholar
• Cohen, P., S. Klumpp, and D. L. Schelling. 1989. An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues. FEBS Lett. 250:596–600.
   PubMed Web of Science ®Google Scholar
• Collins, A. V., D. W. Brodie, R. J. Gilbert, A. Iaboni, R. Manso-Sancho, B. Walse, D. I. Stuart, P. A. van der Merwe, and S. J. Davis. 2002. The interaction properties of costimulatory molecules revisited. Immunity 17:201–210.
   PubMed Web of Science ®Google Scholar
• Cross, D. A., D. R. Alessi, P. Cohen, M. Andjelkovich, and B. A. Hemmings. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785–789.
   PubMed Web of Science ®Google Scholar
• Cuevas, B., Y. Lu, S. Watt, R. Kumar, J. Zhang, K. A. Siminovitch, and G. B. Mills. 1999. SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity. J. Biol. Chem. 274:27583–27589.
   PubMedGoogle Scholar
• Daikh, D., D. Wofsy, and J. B. Imboden. 1997. The CD28-B7 costimulatory pathway and its role in autoimmune disease. J. Leukoc. Biol. 62:156–162.
   PubMed Web of Science ®Google Scholar
• Datta, S. R., A. Brunet, and M. E. Greenberg. 1999. Cellular survival: a play in three Akts. Genes Dev. 13:2905–2927.
   PubMed Web of Science ®Google Scholar
• Fallarino, F., P. E. Fields, and T. F. Gajewski. 1998. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28. J. Exp. Med. 188:205–210.
   PubMed Web of Science ®Google Scholar
• Frauwirth, K. A., J. L. Riley, M. H. Harris, R. V. Parry, J. C. Rathmell, D. R. Plas, R. L. Elstrom, C. H. June, and C. B. Thompson. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity 16:769–777.
   PubMed Web of Science ®Google Scholar
• Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23:515–548.
   PubMed Web of Science ®Google Scholar
• Grohmann, U., C. Orabona, F. Fallarino, C. Vacca, F. Calcinaro, A. Falorni, P. Candeloro, M. L. Belladonna, R. Bianchi, M. C. Fioretti, and P. Puccetti. 2002. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3:1097–1101.
   PubMed Web of Science ®Google Scholar
• Gupta, N., A. M. Scharenberg, D. A. Fruman, L. C. Cantley, J. P. Kinet, and E. O. Long. 1999. The SH2 domain-containing inositol 5′-phosphatase (SHIP) recruits the p85 subunit of phosphoinositide 3-kinase during Fcγ RIIb1-mediated inhibition of B cell receptor signaling. J. Biol. Chem. 274:7489–7494.
   PubMed Web of Science ®Google Scholar
• Hughes, T. R., M. Mao, A. R. Jones, J. Burchard, M. J. Marton, K. W. Shannon, S. M. Lefkowitz, M. Ziman, J. M. Schelter, M. R. Meyer, S. Kobayashi, C. Davis, H. Dai, Y. D. He, S. B. Stephaniants, G. Cavet, W. L. Walker, A. West, E. Coffey, D. D. Shoemaker, R. Stoughton, A. P. Blanchard, S. H. Friend, and P. S. Linsley. 2001. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat. Biotechnol. 19:342–347.
   PubMed Web of Science ®Google Scholar
• Imboden, J. B., and G. A. Koretsky. 1995. Intracellular signalling. Switching off signals. Curr. Biol. 5:727–729.
   PubMedGoogle Scholar
• Ivaska, J., L. Nissinen, N. Immonen, J. E. Eriksson, V. M. Kahari, and J. Heino. 2002. Integrin α2β1 promotes activation of protein phosphatase 2A and dephosphorylation of Akt and glycogen synthase kinase 3β. Mol. Cell. Biol. 22:1352–1359.
   PubMedGoogle Scholar
• Jones, R. G., M. Parsons, M. Bonnard, V. S. Chan, W. C. Yeh, J. R. Woodgett, and P. S. Ohashi. 2000. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J. Exp. Med. 191:1721–1734.
   PubMedGoogle Scholar
• Kane, L. P., P. G. Andres, K. C. Howland, A. K. Abbas, and A. Weiss. 2001. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not T(H)2 cytokines. Nat. Immunol. 2:37–44.
   PubMed Web of Science ®Google Scholar
• Krauss, S., M. D. Brand, and F. Buttgereit. 2001. Signaling takes a breath-new quantitative perspectives on bioenergetics and signal transduction. Immunity 15:497–502.
   PubMed Web of Science ®Google Scholar
• Lee, K. M., E. Chuang, M. Griffin, R. Khattri, D. K. Hong, W. G. Zhang, D. Straus, L. E. Samelson, C. B. Thompson, and J. A. Bluestone. 1998. Molecular basis of T cell inactivation by CTLA-4. Science 282:2263–2266.
   PubMed Web of Science ®Google Scholar
• Leverrier, Y., J. Thomas, A. L. Mathieu, W. Low, B. Blanquier, and J. Marvel. 1999. Role of PI3-kinase in Bcl-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells. Cell Death Differ. 6:290–296.
   PubMedGoogle Scholar
• Levine, B. L., W. B. Bernstein, M. Connors, N. Craighead, T. Lindsten, C. B. Thompson, and C. H. June. 1997. Effects of CD28 costimulation on long-term proliferation of CD4(+) T cells in the absence of exogenous feeder cells. J. Immunol. 159:5921–5930.
   PubMed Web of Science ®Google Scholar
• Lu, Y., Q. Yu, J. H. Liu, J. Zhang, H. Wang, D. Koul, J. S. McMurray, X. Fang, W. K. A. Yung, K. A. Siminovitch, and G. B. Mills. 2003. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. J. Biol. Chem. 278:40057–40066.
   PubMed Web of Science ®Google Scholar
• Marengere, L. E., P. Waterhouse, G. S. Duncan, H. W. Mittrucker, G. S. Feng, and T. W. Mak. 1996. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272:1170–1173.
   PubMed Web of Science ®Google Scholar
• Masteller, E. L., E. Chuang, A. C. Mullen, S. L. Reiner, and C. B. Thompson. 2000. Structural analysis of CTLA-4 function in vivo. J. Immunol. 164:5319–5327.
   PubMed Web of Science ®Google Scholar
• Mellor, A. L., and D. H. Munn. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4:762–774.
   PubMed Web of Science ®Google Scholar
• Millward, T. A., S. Zolnierowicz, and B. A. Hemmings. 1999. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24:186–191.
   PubMed Web of Science ®Google Scholar
• Munn, D. H., M. D. Sharma, and A. L. Mellor. 2004. Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 172:4100–4110.
   PubMed Web of Science ®Google Scholar
• Namboodiripad, A. N., and M. L. Jennings. 1996. Permeability characteristics of erythrocyte membrane to okadaic acid and calyculin A. Am. J. Physiol. 270:C449–C456.
   PubMedGoogle Scholar
• Nishimura, H., N. Minato, T. Nakano, and T. Honjo. 1998. Immunological studies on PD-1-deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int. Immunol. 10:1563–1572.
   PubMed Web of Science ®Google Scholar
• Okazaki, T., A. Maeda, H. Nishimura, T. Kurosaki, and T. Honjo. 2001. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. USA 98:13866–13871.
   PubMed Web of Science ®Google Scholar
• Oosterwegel, M. A., D. A. Mandelbrot, S. D. Boyd, R. B. Lorsbach, D. Y. Jarrett, A. K. Abbas, and A. H. Sharpe. 1999. The role of CTLA-4 in regulating Th2 differentiation. J. Immunol. 163:2634–2639.
   PubMed Web of Science ®Google Scholar
• Pages, F., M. Ragueneau, R. Rottapel, A. Truneh, J. Nunes, J. Imbert, and D. Olive. 1994. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature 369:327–329.
   PubMed Web of Science ®Google Scholar
• Parry, R. V., K. Reif, G. Smith, D. M. Sansom, B. A. Hemmings, and S. G. Ward. 1997. Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase B. Eur. J. Immunol. 27:2495–2501.
   PubMedGoogle Scholar
• Parry, R. V., C. A. Rumbley, L. H. Vandenberghe, C. H. June, and J. L. Riley. 2003. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-x(L), and IL-2 expression in primary human CD4 T lymphocytes. J. Immunol. 171:166–174.
   PubMed Web of Science ®Google Scholar
• Phan, G. Q., J. C. Yang, R. M. Sherry, P. Hwu, S. L. Topalian, D. J. Schwartzentruber, N. P. Restifo, L. R. Haworth, C. A. Seipp, L. J. Freezer, K. E. Morton, S. A. Mavroukakis, P. H. Duray, S. M. Steinberg, J. P. Allison, T. A. Davis, and S. A. Rosenberg. 2003. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA 100:8372–8377.
   PubMed Web of Science ®Google Scholar
• Probst, H. C., K. McCoy, T. Okazaki, T. Honjo, and B. M. van den. 2005. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6:280–286.
   PubMed Web of Science ®Google Scholar
• Rathmell, J. C., R. L. Elstrom, R. M. Cinalli, and C. B. Thompson. 2003. Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma. Eur. J. Immunol. 33:2223–2232.
   PubMed Web of Science ®Google Scholar
• Riley, J. L., and C. H. June. 2005. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 105:13–21.
   PubMed Web of Science ®Google Scholar
• Riley, J. L., M. Mao, S. Kobayashi, M. Biery, J. Burchard, G. Cavet, B. P. Gregson, C. H. June, and P. S. Linsley. 2002. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl. Acad. Sci. USA 99:11790–11795.
   PubMed Web of Science ®Google Scholar
• Rudd, C. E., and H. Schneider. 2003. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 3:544–556.
   PubMed Web of Science ®Google Scholar
• Salama, A. D., T. Chitnis, J. Imitola, H. Akiba, F. Tushima, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury. 2003. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198:71–78.
   PubMed Web of Science ®Google Scholar
• Sheppard, K. A., L. J. Fitz, J. M. Lee, C. Benander, J. A. George, J. Wooters, Y. Qiu, J. M. Jussif, L. L. Carter, C. R. Wood, and D. Chaudhary. 2004. PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS Lett. 574:37–41.
   PubMed Web of Science ®Google Scholar
• Shlapatska, L. M., S. V. Mikhalap, A. G. Berdova, O. M. Zelensky, T. J. Yun, K. E. Nichols, E. A. Clark, and S. P. Sidorenko. 2001. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J. Immunol. 166:5480–5487.
   PubMedGoogle Scholar
• Song, J., S. Salek-Ardakani, P. R. Rogers, M. Cheng, L. Van Parijs, and M. Croft. 2004. The costimulation-regulated duration of PKB activation controls T cell longevity. Nat. Immunol. 5:150–158.
   PubMed Web of Science ®Google Scholar
• Suh, W. K., B. U. Gajewska, H. Okada, M. A. Gronski, E. M. Bertram, W. Dawicki, G. S. Duncan, J. Bukczynski, S. Plyte, A. Elia, A. Wakeham, A. Itie, S. Chung, J. Da Costa, S. Arya, T. Horan, P. Campbell, K. Gaida, P. S. Ohashi, T. H. Watts, S. K. Yoshinaga, M. R. Bray, M. Jordana, and T. W. Mak. 2003. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat. Immunol. 4:899–906.
   PubMed Web of Science ®Google Scholar
• Tivol, E. A., A. N. Schweitzer, and A. H. Sharpe. 1996. Costimulation and autoimmunity. Curr. Opin. Immunol. 8:822–830.
   PubMedGoogle Scholar
• Vander Heiden, M. G., D. R. Plas, J. C. Rathmell, C. J. Fox, M. H. Harris, and C. B. Thompson. 2001. Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol. Cell. Biol. 21:5899–5912.
   PubMed Web of Science ®Google Scholar
• Vlahos, C. J., W. F. Matter, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241–5248.
   PubMed Web of Science ®Google Scholar
• Wang, J., and M. F. Wilkinson. 2000. Site-directed mutagenesis of large (13-kb) plasmids in a single-PCR procedure. BioTechniques 29:976–978.
   PubMedGoogle Scholar
• Ward, S. G., J. Westwick, N. D. Hall, and D. M. Sansom. 1993. Ligation of CD28 receptor by B7 induces formation of D-3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation. Eur. J. Immunol. 23:2572–2577.
   PubMedGoogle Scholar
• Watanabe, N., M. Gavrieli, J. R. Sedy, J. Yang, F. Fallarino, S. K. Loftin, M. A. Hurchla, N. Zimmerman, J. Sim, X. Zang, T. L. Murphy, J. H. Russell, J. P. Allison, and K. M. Murphy. 2003. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4:670–679.
   PubMed Web of Science ®Google Scholar
• Whetton, A. D., G. W. Bazill, and T. M. Dexter. 1984. Haemopoietic cell growth factor mediates cell survival via its action on glucose transport. EMBO J. 3:409–413.
   PubMed Web of Science ®Google Scholar
• Wu, C. J., D. M. O'Rourke, G. S. Feng, G. R. Johnson, Q. Wang, and M. I. Greene. 2001. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors. Oncogene 20:6018–6025.
   PubMed Web of Science ®Google Scholar
• Yi, L. A., S. Hajialiasgar, and E. Chuang. 2004. Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo. Int. Immunol. 16:539–547.
   PubMedGoogle Scholar
• Zhang, S. Q., W. G. Tsiaras, T. Araki, G. Wen, L. Minichiello, R. Klein, and B. G. Neel. 2002. Receptor-specific regulation of phosphatidylinositol 3′-kinase activation by the protein tyrosine phosphatase Shp2. Mol. Cell. Biol. 22:4062–4072.
   PubMed Web of Science ®Google Scholar